BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 867465)

  • 21. A clinical evaluation of citrate-phosphate-dextrose-adenine blood.
    Kreuger A; Akerblom O; Högman CF
    Vox Sang; 1975; 29(2):81-9. PubMed ID: 807039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of ascorbate and dihydroxyacetone on the 2,3-diphosphoglycerate and ATP levels of stored human red cells.
    Wood L; Beutler E
    Transfusion; 1974; 14(3):272-7. PubMed ID: 4835952
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved red blood cell storage using optional additive systems (OAS) containing adenine, glucose and ascorbate-2-phosphate.
    Moore GL; Ledford ME; Brummell MR
    Transfusion; 1981; 21(6):723-31. PubMed ID: 7314223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
    Beutler E; West C
    J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin function in stored blood. XIII. A citrate-adenine preservative with optimal pH to maintain red cell 2,3-DPG (function) and ATP (viability).
    Dawson RB; Kocholaty WF; Camp R; Crater D; Ellis TJ; Spurlock W; Billings TA; Ledford EB
    Haematologia (Budap); 1975; 9(1-2):49-57. PubMed ID: 7517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of blood oxygen affinity in dogs by infusion of glycolytic intermediates.
    Bristow JD; Metcalfe J; Krall MA; Welch JE; Black JA; Dhindsa DS
    J Appl Physiol Respir Environ Exerc Physiol; 1977 Jul; 43(1):102-6. PubMed ID: 893250
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood preservation XXVI, CPD-adenine packed cells: benefits of increasing the glucose.
    Dawson RB; Hershey RT; Myers C; Holmes S
    Transfusion; 1978; 18(3):339-346. PubMed ID: 664002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolism of packed erythrocytes stored in CPD-adenine.
    Bensinger TA; Metro J; Beutler E
    Transfusion; 1975; 15(2):135-9. PubMed ID: 1118878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood preservation 42: improvement of ascorbate's ability to maintain 2,3-DPG with inosine.
    Dawson RB; Meyer DR; Hershey RT; Meyers-Hilbert C; Miller RM
    Transfusion; 1981; 21(3):285-90. PubMed ID: 7233512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro evaluation of modifications in CPD-adenine anticoagulated-preserved blood at various hematocrits.
    Moore GL; Ledford ME; Peck CC
    Transfusion; 1980; 20(4):419-26. PubMed ID: 7404640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of inosine, inorganic phosphates and pyruvate on erythrocyte glycolysis metabolites under conditions of preservation].
    Hasart E; Roigas H; Roth W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(4):559-72. PubMed ID: 64396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-week red cell storage with preservation of 2,3 DPG.
    Carmen RA; Sohmer PR; Leng BS; Moore GL; Nelson EJ; Simon TL; Myhre BA; Marcus CS; Moroff G; Lewis LM
    Transfusion; 1988; 28(2):157-61. PubMed ID: 3354043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of additives on red cell 2,3 diphosphoglycerate levels in CPDA preservatives.
    Vora S; West C; Beutler E
    Transfusion; 1989; 29(3):226-9. PubMed ID: 2922791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkaline CPD and the preservation of RBC 2,3-DPG.
    Hess JR; Hill HR; Oliver CK; Lippert LE; Greenwalt TJ
    Transfusion; 2002 Jun; 42(6):747-52. PubMed ID: 12147028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of ITP and ATP and regeneration of 2,3-DPG in human erythrocytes incubated with adenosine, pyruvate and inorganic phosphate.
    Zachara B
    Transfusion; 1977; 17(6):628-34. PubMed ID: 595119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infusion of physiological saline supplemented with adenine, pyruvate and phosphate.
    Rudowski W; Daszyński J; Schier J; Kowalczyk N; Gaczkowski A; Góralski S
    Haematologia (Budap); 1977; 11(1-2):127-32. PubMed ID: 615084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood preservation. XXVIII. Galactose and maltose maintain red blood cell 2,3-DPG and ATP.
    Dawson RB; Hershey RT; Myers CS; Zuck TF
    Transfusion; 1980; 20(1):110-3. PubMed ID: 7355460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved maintenance of 2,3 DPG and ATP in RBCs stored in a modified additive solution.
    Högman CF; Knutson F; Lööf H; Payrat JM
    Transfusion; 2002 Jul; 42(7):824-9. PubMed ID: 12375653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood preservation. XLIII. Studies on the ascorbate mechanisms of maintaining red cell 2,3-DPG.
    Dawson RB; Dabezies M; Hershey RT; Myers CS; Miller RM
    Transfusion; 1980; 20(3):316-20. PubMed ID: 7385326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Half-strength citrate CPD and new additive solutions for improved blood preservation. I. Studies of six experimental solutions.
    Högman CF; Eriksson L; Gong J; Payrat JM; Debrauwere J
    Transfus Med; 1993 Mar; 3(1):43-50. PubMed ID: 8038896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.